# Prevention Relapse of Graves' Disease by Intrathyroid Injection of Dexamethasone

> **NCT00917241** · PHASE4 · COMPLETED · sponsor: **Xiao-Ming Mao** · enrollment: 218 (actual)

## Conditions studied

- Graves' Disease

## Interventions

- **DRUG:** MMI combined with IID
- **DRUG:** MMI

## Key facts

- **NCT ID:** NCT00917241
- **Lead sponsor:** Xiao-Ming Mao
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2008-12
- **Final completion:** 2009-03
- **Target enrollment:** 218 (ACTUAL)
- **Last updated:** 2013-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00917241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00917241, "Prevention Relapse of Graves' Disease by Intrathyroid Injection of Dexamethasone". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00917241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*